Abstract:No standard exists for venous thromboembolism (VTE) prophylaxis after traumatic brain injury (TBI). Caregivers agree that there is an early time point after injury in which the chances of spontaneous injury progression are high and the risks of prophylactic anticoagulation are excessive, and that these injuries eventually stabilize to the point that anticoagulation may be safely started. Translating this consensus into an application that can inform bedside decision making has not occurred. National groups hav… Show more
“…Although the use of chemical VTE prophylaxis in patients with head injuries appears to be safe, adoption is slow and prospective trials are lacking. 16,17 Limitations Limitations of our study are related to the retrospective nature and lack of controlled protocol for chemical VTE initiation at our centre. While patients were similar in age, sex and injury scores, there was a significant differ ence in the percentage of highgrade splenic injuries, which could be a confounding factor and may highlight a reluctance to initiate chemical VTE prophylaxis in this particular subset of patients, leading to a selection bias that was unlikely to be overcome by using a larger sample size.…”
Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safeBackground: The optimal timing of initiating low-molecular weight heparin (LMWH) in patients who have undergone nonoperative management (NOM) of blunt solid organ injuries (SOIs) remains controversial. We describe the safety of early initiation of chemical venous thromboembolism (VTE) prophylaxis among patients undergoing NOM of blunt SOIs.
Methods:We retrospectively studied severely injured adults who sustained blunt SOI without significant intracranial hemorrhage and underwent an initial NOM at a Can adian lead trauma hospital between 2010 and 2014. Safety was assessed based on failure of NOM, defined as the need for operative intervention, in patients who received early (< 48 h) or late LMWH (≥ 48 h, or early discharge [< 72 h] without LMWH).
Results:We included 162 patients in our analysis. Most were men (69%), and the aver age age was 42 ± 18 years. The median injury severity score was 17, and splenic injuries were most common (97 [60%], median grade 2), followed by liver (57 [35%], median grade 2) and kidney injuries (31 [19%], median grade 1). Combined injuries were present in 14% of patients. A total of 78 (48%) patients received early LMWH, while 84 (52%) received late LMWH. The groups differed only in percent of highgrade splenic injury (14% v. 32%). Overall 2% of patients failed NOM, none after receiving LMWH. Semielective angiography was performed in 23 (14%) patients. The overall rate of con firmed VTE on imaging was 1.9%.
Conclusion:Early initiation of medical thromboembolic prophylaxis appears safe in select patients with isolated SOI following blunt trauma. A prospective multicentre study is warranted.
Contexte :Le moment optimal pour commencer le traitement à l'héparine de bas poids moléculaire (HBPM) chez les patients ayant subi un traumatisme fermé à un organe plein (TFOP) avec prise en charge non chirurgicale (PCNC) demeure un sujet controversé. Nous décrivons l'innocuité d'une initiation hâtive de la chimioprophy laxie de la thromboembolie veineuse (TEV) chez les patients dont le TFOP est pris en charge de façon non chirurgicale.Méthodes : Nous avons étudié rétrospectivement les cas d'adultes gravement blessés ayant subi un TFOP sans hémorragie intracrânienne importante pris en charge de façon non chirurgicale dans un hôpital canadien de premier plan spécialisé en trauma tologie entre 2010 et 2014. L'innocuité a été évaluée en fonction du taux d'échec de la PCNC, défini comme la nécessité de recourir à une intervention chirurgicale, chez des patients qui ont reçu de l'HBPM plus tôt (< 48 h) ou plus tard (≥ 48 h, ou qui ont reçu un congé précoce [< 72 h]).
“…Although the use of chemical VTE prophylaxis in patients with head injuries appears to be safe, adoption is slow and prospective trials are lacking. 16,17 Limitations Limitations of our study are related to the retrospective nature and lack of controlled protocol for chemical VTE initiation at our centre. While patients were similar in age, sex and injury scores, there was a significant differ ence in the percentage of highgrade splenic injuries, which could be a confounding factor and may highlight a reluctance to initiate chemical VTE prophylaxis in this particular subset of patients, leading to a selection bias that was unlikely to be overcome by using a larger sample size.…”
Very early initiation of chemical venous thromboembolism prophylaxis after blunt solid organ injury is safeBackground: The optimal timing of initiating low-molecular weight heparin (LMWH) in patients who have undergone nonoperative management (NOM) of blunt solid organ injuries (SOIs) remains controversial. We describe the safety of early initiation of chemical venous thromboembolism (VTE) prophylaxis among patients undergoing NOM of blunt SOIs.
Methods:We retrospectively studied severely injured adults who sustained blunt SOI without significant intracranial hemorrhage and underwent an initial NOM at a Can adian lead trauma hospital between 2010 and 2014. Safety was assessed based on failure of NOM, defined as the need for operative intervention, in patients who received early (< 48 h) or late LMWH (≥ 48 h, or early discharge [< 72 h] without LMWH).
Results:We included 162 patients in our analysis. Most were men (69%), and the aver age age was 42 ± 18 years. The median injury severity score was 17, and splenic injuries were most common (97 [60%], median grade 2), followed by liver (57 [35%], median grade 2) and kidney injuries (31 [19%], median grade 1). Combined injuries were present in 14% of patients. A total of 78 (48%) patients received early LMWH, while 84 (52%) received late LMWH. The groups differed only in percent of highgrade splenic injury (14% v. 32%). Overall 2% of patients failed NOM, none after receiving LMWH. Semielective angiography was performed in 23 (14%) patients. The overall rate of con firmed VTE on imaging was 1.9%.
Conclusion:Early initiation of medical thromboembolic prophylaxis appears safe in select patients with isolated SOI following blunt trauma. A prospective multicentre study is warranted.
Contexte :Le moment optimal pour commencer le traitement à l'héparine de bas poids moléculaire (HBPM) chez les patients ayant subi un traumatisme fermé à un organe plein (TFOP) avec prise en charge non chirurgicale (PCNC) demeure un sujet controversé. Nous décrivons l'innocuité d'une initiation hâtive de la chimioprophy laxie de la thromboembolie veineuse (TEV) chez les patients dont le TFOP est pris en charge de façon non chirurgicale.Méthodes : Nous avons étudié rétrospectivement les cas d'adultes gravement blessés ayant subi un TFOP sans hémorragie intracrânienne importante pris en charge de façon non chirurgicale dans un hôpital canadien de premier plan spécialisé en trauma tologie entre 2010 et 2014. L'innocuité a été évaluée en fonction du taux d'échec de la PCNC, défini comme la nécessité de recourir à une intervention chirurgicale, chez des patients qui ont reçu de l'HBPM plus tôt (< 48 h) ou plus tard (≥ 48 h, ou qui ont reçu un congé précoce [< 72 h]).
“…Traumatic brain injury (TBI) patients treated in the intensive care unit (ICU) appear at high risk for venous thromboembolism (VTE), such as deep venous thrombosis (DVT) of the legs and pulmonary embolism (PE) [1][2][3]. Moreover, the occurrence of massive PE is a known cause of late death in trauma patients, and the risk is increased in patients with DVT [4,5].…”
Despite mechanical and pharmacological prophylaxis, VTE occurs in one out of every five patients with TBI treated in the ICU. Higher age, greater weight and greater severity of TBI increase the risk. The development of VTE was not associated with excess mortality.
“…4,5 In 2012, we published a study of 245 patients with at least two CT scans of the head who had been classified and followed per this original iteration of the Parkland Protocol between February 2010 and March 2011. 3 In that study, we found that spontaneous progression of hemorrhage occurred in 25% of subjects in the low-risk arm (n = 136), 43% of moderate-risk subjects (n = 42), and 64% of high-risk subjects (n = 67).…”
Section: Discussionmentioning
confidence: 99%
“…In recognition of this spectrum of risk, we have constructed and promulgated a theoretical treatment algorithm for VTE prophylaxis after TBI, which we are calling the ''Parkland Protocol.'' 4,5 Based on a modification of injury patterns initially put forth by Berne and Norwood, 6-8 our original protocol and its subsequent iterations classify TBI patients as low, moderate, or high risk for spontaneous progression of their intracranial hemorrhage (ICH) pattern and tailor a VTE prophylaxis regimen to each arm (Fig. 1).…”
As a basis for venous thromboembolism (VTE) prophylaxis after traumatic brain injury (TBI), we have previously published an algorithm known as the Parkland Protocol. Patients are classified by risk for spontaneous progression of hemorrhage with chemoprophylaxis regimens tailored to each tier. We sought to validate this schema. In our algorithm, patients with any of the following are classified ''low risk'' for spontaneous progression: subdural hemorrhage £ 8 mm thick; epidural hemorrhage £ 8 mm thick; contusions £ 20 mm in diameter; a single contusion per lobe; any amount of subarachnoid hemorrhage; or any amount of intraventricular hemorrhage. Patients with any injury exceeding these are ''moderate risk'' for progression, and any patient receiving a monitor or craniotomy is ''high risk.'' From February 2010 to November 2012, TBI patients were entered into a dedicated database tracking injury types and sizes, risk category at presentation, and progression on subsequent computed tomgraphies (CTs). The cohort (n = 414) was classified as low risk (n = 200), moderate risk (n = 75), or high risk (n = 139) after first CT. After repeat CT scan, radiographic progression was noted in 27% of low-risk, 53% of moderate-risk, and 58% of high-risk subjects. Omnibus analysis of variance test for differences in progression rates was highly significant ( p < 0.0001). Tukey's post-hoc test showed the low-risk progression rate to be significantly different than both the moderate-and high-risk arms; no difference was noted between the moderate-and high-risk arms themselves. These criteria are a valid tool for classifying TBI patients into two categories of risk for spontaneous progression. This supports tailored chemoprophylaxis regimens for each arm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.